Which action is associated with State Boards after inspections?

• A. Setting prescription drug prices.
• B. Approving new drug formulations.
• C. Conducting random chemical testing of medications.
• D. Responding to complaints or handling noncompliance detected at an inspection.

Answer: (D)

After an inspection, the board focuses on addressing any problems found and ensuring ongoing compliance. When issues are identified or complaints arise, the board’s role is to handle noncompliance detected during inspections—this includes issuing sanctions or citations, requiring corrective action plans, and following up to verify deficiencies are fixed. This is how enforcement and ongoing oversight are carried out.

The other actions don’t fit this role. Setting prescription drug prices isn’t done by state boards. Approving new drug formulations is the purview of federal regulators, not post-inspection boards. Random chemical testing of medications is typically performed by manufacturers’ quality control or regulatory laboratories, not as a post-inspection action by state boards.